Hall E J
Center for Radiological Research, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Radiology. 1991 May;179(2):297-306. doi: 10.1148/radiology.179.2.2014268.
Over the past 200 years, a bewildering array of chemical, physical, and viral agents has been identified that can cause cancer, but the mechanisms involved are only now becoming clear. In the leukemias and lymphomas, it appears that the activation of cellular oncogenes is important. The genes involved are present in all normal cells and are often associated with cell growth and regulation. When activated, they act in a dominant fashion to cause a cell to express the malignant phenotype. There is increasing evidence that in solid tumors, a more important mechanism may be the loss of a suppressor gene. The classic example is retinoblastoma, in which the retinoblastoma gene has been cloned and is also found to be associated with several other common cancers including sarcomas and small cell lung cancer. It is likely to be one of a family of such genes. It may well be that the activation of one or more oncogenes or the loss of one or more suppressor genes, or both, is required for a tumor to progress from initiation through promotion to a metastasizing malignancy.
在过去的200年里,人们已经识别出一系列令人眼花缭乱的化学、物理和病毒因子可导致癌症,但其中涉及的机制直到现在才逐渐明晰。在白血病和淋巴瘤中,细胞癌基因的激活似乎很重要。相关基因存在于所有正常细胞中,且常常与细胞生长和调控有关。一旦被激活,它们以显性方式发挥作用,使细胞表现出恶性表型。越来越多的证据表明,在实体瘤中,一个更重要的机制可能是抑癌基因的缺失。经典的例子是视网膜母细胞瘤,其中视网膜母细胞瘤基因已被克隆,并且还发现它与其他几种常见癌症有关,包括肉瘤和小细胞肺癌。它很可能是这类基因家族中的一员。肿瘤从起始经过促进阶段发展为转移性恶性肿瘤,很可能需要一个或多个癌基因的激活,或一个或多个抑癌基因的缺失,或两者皆有。